Gut Microbiota in Cardiovascular Health and Disease
2017/03/30 by W.H. Wilson Tang, Takeshi Kitai, Stanley L. Hazen · 33 citations
Medicine · Biochemistry, Genetics and Molecular Biology · #Diet and metabolism studies #Gut microbiota and health #Gastrointestinal motility and disorders
paper · pdf · doi:10.1161/circresaha.117.309715
Abstract
Significant interest in recent years has focused on gut microbiota–host interaction because accumulating evidence has revealed that intestinal microbiota play an important role in human health and disease, including cardiovascular diseases. Changes in the composition of gut microbiota associated with disease, referred to as dysbiosis, have been linked to pathologies such as atherosclerosis, hypertension, heart failure, chronic kidney disease, obesity, and type 2 diabetes mellitus. In addition to alterations in gut microbiota composition, the metabolic potential of gut microbiota has been identified as a contributing factor in the development of diseases. Recent studies revealed that gut microbiota can elicit a variety of effects on the host. Indeed, the gut microbiome functions like an endocrine organ, generating bioactive metabolites, that can impact host physiology. Microbiota interact with the host through many pathways, including the trimethylamine/trimethylamine N -oxide pathway, short-chain fatty acids pathway, and primary and secondary bile acids pathways. In addition to these metabolism-dependent pathways, metabolism-independent processes are suggested to also potentially contribute to cardiovascular disease pathogenesis. For example, heart failure–associated splanchnic circulation congestion, bowel wall edema, and impaired intestinal barrier function are thought to result in bacterial translocation, the presence of bacterial products in the systemic circulation and heightened inflammatory state. These are thought to also contribute to further progression of heart failure and atherosclerosis. The purpose of the current review is to highlight the complex interplay between microbiota, their metabolites, and the development and progression of cardiovascular diseases. We will also discuss the roles of gut microbiota in normal physiology and the potential of modulating intestinal microbial inhabitants as novel therapeutic targets.
Citations
Cited by
- From the gut to disease: Microbiota-derived short chain fatty acids and their precursors lactate and succinate in atherosclerosis and cancer
- The human microbiome in space: parallels between Earth-based dysbiosis, implications for long-duration spaceflight, and possible mitigation strategies
- A lack of commensal microbiota influences the male reproductive tract intergenerationally in mice
- Impact of the gut microbiome on atherosclerosis
- Suppression of gut dysbiosis reverses Western diet-induced vascular dysfunction
- The epithelial barrier theory and its associated diseases
- Gut‐on‐a‐chip platforms: Bridging in vitro and in vivo models for advanced gastrointestinal research
- Ergothioneine attenuates whole-abdominal irradiation-induced multi-organ injury via the gut-heart-brain axis by modulating calcium voltage-gated channel subunit alpha1 C (Cacna1c) expression
- Proteobacteria: A Common Factor in Human Diseases. [europepmc]
- Elevated circulating levels of succinate in human obesity are linked to specific gut microbiota. [europepmc]
- Inflammation in sickle cell disease. [europepmc]
- The Gut Microbiome Profile in Obesity: A Systematic Review. [europepmc]
- Inflammation, Immunity, and Infection in Atherothrombosis: JACC Review Topic of the Week. [europepmc]
- New insights into oxidative stress and inflammation during diabetes mellitus-accelerated atherosclerosis. [europepmc]
- Microbial impact on cholesterol and bile acid metabolism: current status and future prospects. [europepmc]
- Diet, Gut Microbiota, and Obesity: Links with Host Genetics and Epigenetics and Potential Applications. [europepmc]
- Intestinal Microbiota in Cardiovascular Health and Disease: JACC State-of-the-Art Review. [europepmc]
- Biomarkers of Oxidative Stress in Metabolic Syndrome and Associated Diseases. [europepmc]
- The Two-Way Polyphenols-Microbiota Interactions and Their Effects on Obesity and Related Metabolic Diseases. [europepmc]
- Citrus polymethoxyflavones attenuate metabolic syndrome by regulating gut microbiome and amino acid metabolism. [europepmc]
- Inflamm-ageing: the role of inflammation in age-dependent cardiovascular disease. [europepmc]
- Role of Endothelial Dysfunction in Cardiovascular Diseases: The Link Between Inflammation and Hydrogen Sulfide. [europepmc]
- Gut microbiota and cardiovascular disease: opportunities and challenges. [europepmc]
- The gut microbial metabolite trimethylamine N-oxide aggravates GVHD by inducing M1 macrophage polarization in mice. [europepmc]
- Gut Microbiome, Intestinal Permeability, and Tissue Bacteria in Metabolic Disease: Perpetrators or Bystanders? [europepmc]
- Gut microbiota and Covid-19- possible link and implications. [europepmc]
- Gut Microbiota in Hypertension and Atherosclerosis: A Review. [europepmc]
- Environmental Endocrine-Disrupting Chemical Exposure: Role in Non-Communicable Diseases. [europepmc]
- Obesity cardiomyopathy: evidence, mechanisms, and therapeutic implications. [europepmc]
- Interaction between Lipopolysaccharide and Gut Microbiota in Inflammatory Bowel Diseases. [europepmc]
- Role of the gut microbiome in chronic diseases: a narrative review. [europepmc]
- Pathophysiology of Atherosclerosis. [europepmc]
- Human gut microbiota in health and disease: Unveiling the relationship. [europepmc]
Related